Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction

International Heart Journal

Volumn 54, Issue 4, 2013, Pages 185-191

  Sim, Doo Sun ^a   Ahn, Youngkeun ^a   Jeong, Myung Ho ^a   Kim, Young Jo ^b   Chae, Shung Chull ^c   Hong, Taek Jong ^d   Seong, In Whan ^e   Chae, Jei Keon ^f   Kim, Chong Jin ^g   Cho, Myeong Chan ^f   Seung, Ki Bae ^h  

^a Chonnam National University Medical School   (South Korea)

^b Young Nam University Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

^e Chungnam National University College of Medicine   (South Korea)

^f Chungbuk National University Hospital   (South Korea)

^g Kyung Hee University College of Medicine   (South Korea)

^h The Catholic University of Korea   (South Korea)

Author keywords

Myocardial infarction; Revascularization; Stent; Treatment

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL;

EID: 84881266804     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.54.185     Document Type: Article

References (21)

1. Giannoglou GD, Antoniadis A P, Chatzizisis YS, Damvopoulou E, Parcharidis GE, Louridas GE. Prevalence of narrowing > or = 50% of the left main coronary artery among 17,300 patients having coronary angiography. Am J Cardiol 2006; 98: 1202-1205.
2. Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 2008; 155: 274-283. (Review)
3. Rodés-Cabau J, Deblois J, Bertrand OF, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008; 118: 2374-2381.
4. Serruys PW, Morice MC, Kappetein A P, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
5. Lee MS, Tseng CH, Barker CM, et al. Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg 2008; 86: 29-34.
6. Lee MS, Sillano D, Latib A, et al. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction. Catheter Cardiovasc Interv 2009; 73: 15-21.
7. Lee SW, Hong MK, Lee CW, et al. Early and late clinical outcomes after primary stenting of the unprotected left main coronary artery stenosis in the setting of acute myocardial infarction. Int J Cardiol 2004; 97: 73-76.
8. Tan CH, Hong MK, Lee CW, et al. Percutaneous coronary intervention with stenting of left main coronary artery with drug-elut-ing stent in the setting of acute ST elevation myocardial infarction. Int J Cardiol 2008; 126: 224-228.
9. Prasad SB, Whitbourn R, Malaiapan Y, Ahmar W, MacIsaac A, Meredith IT. Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis. Catheter Cardiovasc Interv 2009; 73: 301-7.
10. Shemin RJ. Coronary artery bypass grafting versus stenting for unprotected left main coronary artery disease: where lies the body of proof? Circulation 2008; 118: 2326-2329. (Review)
11. Montalescot G, Brieger D, Eagle KA, et al. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J 2009; 30: 2308-2317.
12. Sim DS, Kim JH, Jeong MH. Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea. Korean Circ J 2009; 39: 297-303.
13. Sim DS, Jeong MH, Kang JC. Current management of acute myo-cardial infarction: experience from the Korea Acute Myocardial Infarction Registry. J Cardiol 2010; 56: 1-7. (Review)
14. Palmerini T, Sangiorgi D, Marzocchi A, et al. Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. Am J Cardiol 2010; 105: 174-178.
15. Lee MS, Bokhoor P, Park SJ, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3: 791-795. (Review)
16. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006; 113: 2542-2547.
17. Lee SW, Park SW, Hong MK, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005; 46: 1833-1837.
18. Erglis A, Narbute I, Kumsars I, et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol 2007; 50: 491-497.
19. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006; 47: 864-870.
20. Palmerini T, Marzocchi A, Tamburino C, et al. Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. J Am Coll Cardiol 2009; 53: 1176-1181.
21. Chen K Y, Rha SW, Li YJ, et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2009; 119: 3207-3214.